Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final and Exploratory Results of a Phase I Trial

Post time Half hour(s) ago

journal：International Journal of Radiation Oncology*Biology*Physics

Authors：C. Le Tourneau; X. Liem; T.V.F. Nguyen; S. El Bedoui; S. Salas; M. Plana Serrahima; X. Mirabel; S. Wong Hee Kam; L. Houdas; A. Debard; O.I. Vivar; L.A. Farber; J.O. Thariat; M. Lesnik; F. Helferich; A. Herczeg; Z. Papai; J. Fijuth; Z. Takacsi-Nagy

Published date：2024-4-

DOI：10.1016/j.ijrobp.2024.01.022

PDF link：https://www.sciencedirect.com/sc ... 36030162400066X/pdf

Article link：https://doi.org/10.1016/j.ijrobp.2024.01.022

Article Source：Elsevier BV。

Remark：

Post time Half hour(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Elsevier] Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final and Exploratory Results of a Phase I Trial

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final and Exploratory Results of a Phase I Trial Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Elsevier] Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients: Final and Exploratory Results of a Phase I Trial